Lytix Biopharma: Rekdal returns as CEO Edwin Klumper of Lytix Biopharma has stepped down from his role as CEO. The board has decided to promote Head of R&D Øystein Rekdal to the position of CEO. more ➔
Jane Osbourn joins Mogrify Board British cell therapy expert Mogrify Ltd has appointed Jane Osbourn as Chair of the Board. Osbourn will also become a Member of the Scientific Advisory Board and support Mogrifiy’s executive team in … more ➔
Elcin Barker Ergun becomes Menarini CEO The Board of Directors of Menarini Group has appointed Mrs. Elcin Barker Ergun as CEO. more ➔
PDC*line Pharma welcomes Dr Channa Debruyne PDC*line Pharma, a clinical stage biotech company developing a new class of immunotherapies for cancers announced today that Dr Channa Debruyne joined the company in August as medical director to lead … more ➔
Avillion appoints Dr Anders Gersel Pedersen Avillion LLP, a drug development company focused on the co-development and financing of pharmaceutical candidates, has announced the appointment of Dr Anders Gersel Pedersen as a Non-Executive Director … more ➔
Matthew Call joins Iteos as COO Iteos Therapeutics SA, a privately-held biotechnology company developing novel cancer immunotherapies, last week announced the appointment of Matthew Call as its Chief Operating Officer. Matthew will also … more ➔
Immunic appoints Sanjay S. Patel as CFO Immunic, Inc., a clinical-stage biopharmaceutical company focused on developing potentially best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, … more ➔
Pieris Pharmaceuticals appoints Dr. Maya Said Pieris Pharmaceuticals, Inc. today announced that Maya R. Said, Sc.D., has joined the Company’s Board of Directors. more ➔
Neil Thompson appointed CSO of Healx Healx, a Cambridge, UK, technology company developing treatments for rare diseases, today announces the appointment of Dr Neil Thompson, PhD, as Chief Scientific Officer (CSO). more ➔
Harpreet Singh becomes CEO of Immatics Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical Company active in the discovery and development of T-cell redirecting cancer immunotherapies, today announced that Harpreet Singh has … more ➔
